Publication | Open Access

Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis

Regenerative MedicineTherapeutic BenefitsFibrosisBleomycin-induced Pulmonary FibrosisMedicineAdult Stem CellImmunologyStem Cell ResearchPulmonary FibrosisStem-cell TherapyCell TransplantationMesenchymal Stem CellStem CellsCell BiologyChronic Mouse Model